About Index Trending news
Analyze
Pricing
Trevena

Trevena

Work at Trevena? Add yourself to this profile

Trevena

Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.
Edit Profile
More info

Elsewhere

Companies in the same industry

AgeneBio AgeneBio Bioheart Bioheart Entelos Entelos Morphogen-IX Morphogen-IX LAM Therapeutics LAM Therapeutics Emerus Hospital Partners Emerus Hospital Partners GLO Science GLO Science InSite Vision InSite Vision Molplex Molplex Laurantis Pharma Laurantis Pharma

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
05 Nov 2014
$45,000,000
Post-IPO equity
09 May 2013
$60,000,000
Venture capital (Series C)
Forest Laboratories
14 Jul 2010
$35,000,000
Venture capital (Series B)
Polaris Partners, Alta Partners, HealthCare Ventures, +1
01 Mar 2008
$24,000,000
Venture capital (Series A)
Polaris Partners, Alta Partners, HealthCare Ventures, +1